HLTH:AU:AU-VanEck Global Healthcare Leaders ETF (AUD)

ETF | Others |

Last Closing

USD 11.08

Change

-0.17 (-1.51)%

Market Cap

USD 0.06B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
VAS:AU Vanguard Australian Shares

+0.68 (+0.66%)

USD 16.05B
VAS:AU Vanguard Australian Shares

+0.68 (+0.66%)

USD 16.05B
VGS:AU Vanguard MSCI International Sh..

-1.17 (-0.92%)

USD 8.59B
VGS:AU Vanguard MSCI International Sh..

-1.17 (-0.92%)

USD 8.59B
IVV:AU iShares Core S&P 500 AUD

-0.58 (-1.04%)

USD 8.26B
IVV:AU iShares Core S&P 500 AUD

-0.58 (-1.04%)

USD 8.26B
QUAL:AU VanEck Vectors MSCI World ex A..

-0.53 (-0.97%)

USD 6.31B
QUAL:AU VanEck Vectors MSCI World ex A..

-0.53 (-0.97%)

USD 6.31B
IOZ:AU Ishares Core S&P/Asx 200

+0.14 (+0.42%)

USD 6.10B
IOZ:AU Ishares Core S&P/Asx 200

+0.14 (+0.42%)

USD 6.10B

ETFs Containing HLTH:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.68% 48% F 64% D
Dividend Return 0.87% 8% B- 7% C-
Total Return 8.55% 41% F 62% D
Trailing 12 Months  
Capital Gain 10.03% 37% F 62% D
Dividend Return 0.89% 6% D- 6% D-
Total Return 10.92% 32% F 60% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -0.12% N/A N/A 41% F
Dividend Return 0.20% N/A N/A 39% F
Total Return 0.31% N/A N/A 7% C-
Risk Return Profile  
Volatility (Standard Deviation) 8.23% N/A N/A 93% A
Risk Adjusted Return 2.39% N/A N/A 40% F
Market Capitalization 0.06B 14% F 51% F

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.